Oncotelic Partners With TechForce to Launch AI Robotics

Oncotelic Therapeutics has announced a strategic partnership with TechForce Robotics to commercialize its PDAOAI-enabled, GMP-compliant robotics platform. The clinical-stage biotech company, focused on oncology and AI-driven solutions, calls the deal a significant milestone. The collaboration aims to advance AI-integrated robotics technology meeting Good Manufacturing Practice standards, combining Oncotelic's artificial intelligence capabilities with TechForce's robotics expertise.